Matcha, attention, stress and sleep

Updated 10 Oct 2026

Why it remains an optional purchase

I asked about matcha because I was interested in effects beyond vitamins and minerals. I already own 200 mg caffeine capsules, although ownership does not establish that I take them. For my daily shopping, matcha can be an enjoyable drink to try. The research does not make it another item I need to fit into food I want to eat and can comfortably finish.

The useful questions are whether whole matcha improves something I care about, whether it outperforms caffeine, and whether its effect is large enough to matter. A faster response on one computer task, a saliva measurement and a better night’s sleep are different outcomes.

Has whole matcha beaten caffeine alone?

A 2021 trial assigned 51 Japanese adults aged 50–69 to placebo, caffeine or 2.07 g matcha daily for 12 weeks. The matcha supplied 66.2 mg caffeine and 48 mg theanine; the caffeine arm supplied 66.6 mg caffeine. These were capsules, added to usual diets. Caffeine improved several acute response-time measures. Matcha improved arithmetic work relative to placebo after 12 weeks, but the reported arithmetic comparisons did not establish superiority over caffeine. One acute attention measure also showed more incorrect responses with matcha than placebo. Verbal and visual memory, visual information processing and motor tasks showed no treatment effects. Pairwise comparisons were adjusted within an outcome; the numerous outcomes were not covered by one overall correction. Several authors worked for ITO EN. Original trial.

The distinction is also visible in the current trial registry: Cognitrax and MMSE are primary, and the arithmetic test is secondary. The paper calls the arithmetic test primary. That discrepancy makes the favorable arithmetic finding less persuasive as the main confirmation of the hypothesis.

Selected attention findings are not a general brain benefit

In a small 2017 study, 23 participants attended four sessions with matcha tea, a matcha bar or their placebo counterparts; each matcha product contained 4 g powder. Testing occurred one hour after consumption. The published abstract reports selected improvements in attention and response speed, little effect on most other cognitive tasks, and no mood improvement. The single-blind design and small sample limit confidence. I have inspected the abstract and institutional record, rather than the complete methods and results, so this remains supporting evidence rather than the foundation for a purchase recommendation. Trial abstract.

Another 2021 trial randomized 42 adults aged 25–34 to 2 g matcha or placebo daily for two weeks. Selected attention and emotion-recognition results favored matcha after an arithmetic stress task, while the other cognitive tests did not. It compared matcha with placebo, so it cannot separate the effect from its caffeine. The article reports no improvement in fatigue; the full methods and complete result tables were not accessible in this review. Trial abstract.

Trials of isolated theanine plus caffeine are a separate question. Their comparisons, including a caffeine-only control with a null combination result, are covered in coffee, tea, alertness and sleep. They do not establish what an unspecified matcha product will do.

Stress markers and feeling less stressed

A 2018 study compared two chemically different matcha powders in 39 pharmacy students. Both were matcha, rather than matcha versus a caffeine-free blank. Students consumed 3 g in water daily for 15 days around the start of pharmacy practice. The selected test powder reduced anticipatory anxiety before practice and a morning saliva marker during university days. Anxiety during practice, subjective stress, sleep duration and other questionnaire outcomes did not significantly differ. The researchers also tested mice and surveyed commercial powders; those components of the paper do not validate a human stress-treatment rule for every retail product. University and public research funding supported the study. Original drink trial.

A separate 2019 study involved 36 students consuming cookies containing 4.5 g of one of two matcha powders for 15 days. Morning salivary amylase during pharmacy practice was lower with the selected powder, but anxiety scores and sleep duration did not significantly differ. Both products supplied substantial caffeine, approximately 175 versus 167 mg daily. This supports a preparation-specific biomarker signal; it does not show that I will feel calmer after an ordinary cup. The study had university, public and foundation support. Original cookie trial.

Consequently, I would not buy a more expensive product because someone promises an optimal theanine-to-caffeine ratio. These small human comparisons changed several constituents together and were not dose-finding studies that established a universally effective ratio.

Sleep: the direct measurements were mostly null

A 2024 trial randomized 57 adults and analyzed 46 after exclusions, following four weeks of 2.7 g matcha daily in capsules, supplying 71.5 mg caffeine and 50.3 mg theanine. They were habitual caffeine consumers with generally normal average sleep scores, and avoided the capsules within two hours of bed. Matcha did not significantly improve sleep duration, time to fall asleep, overnight waking or sleep efficiency. Time spent in bed after waking was shorter, with P=.04 among several EEG outcomes and no reported overall multiplicity adjustment. Questionnaire sleep quality and daytime sleepiness did not improve relative to placebo. A reduction in depression scores within the matcha group did not establish a significant between-group improvement; a percentage-change analysis was only a statistical trend. ITO EN sponsored the trial and supplied matcha. These findings do not make matcha a sleep or depression treatment. Original sleep trial.

The longer-term cognitive question is discussed in cocoa, tea and coffee. These findings do not establish protection against other caffeine or late drinking.

Does the training paper justify buying it for recovery?

A 2023 paper reported two small training trials, totaling 36 previously inactive young men. Both compared a matcha beverage supplying 3 g powder daily with a tea-flavored drink matched for caffeine, 90 mg daily. They trained twice weekly with eight exercises and three sets per exercise. In the eight-week trial, matcha did not significantly improve strength or muscle mass over control; an early fatigue rating favored matcha. In the separate 12-week trial, muscle mass increased within the matcha group, but the between-group difference was only a trend. Fat-percentage and salivary-cortisol changes favored matcha in selected analyses, among many tested outcomes. Muscle mass was estimated by bioimpedance; transient microbiome associations did not establish that bacteria caused muscle growth. Nestlé supplied the drinks through a research group that also supported the work. This does not establish extra muscle gain or recovery for my brief sprint and limited-set lifting sessions. Original training paper.

What changes my shopping decision

Matcha earns a place if I enjoy the taste, preparation and price. I would record the product, the amount actually used, other caffeine and how sleep feels, rather than treat the study quantities as a personal regimen. A plain powder, a sweetened latte, whole-leaf capsules and concentrated catechin extracts are different exposures.

For now, the strongest practical reason to try it is an enjoyable drink. The broader caffeine and extract questions are linked in the existing coffee and tea investigation and bioactive-food guide.

Back to investigations